↓ Skip to main content

American Association for Cancer Research

Article Metrics

Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma

Overview of attention for article published in Blood Cancer Discovery, July 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

twitter
132 tweeters

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
36 Mendeley
Title
Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma
Published in
Blood Cancer Discovery, July 2020
DOI 10.1158/2643-3230.bcd-20-0020
Pubmed ID
Authors

Carlos Fernández de Larrea, Mette Staehr, Andrea V. Lopez, Khong Y. Ng, Yunxin Chen, William D. Godfrey, Terence J. Purdon, Vladimir Ponomarev, Hans-Guido Wendel, Renier J. Brentjens, Eric L. Smith

Twitter Demographics

The data shown below were collected from the profiles of 132 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 33%
Student > Ph. D. Student 5 14%
Student > Bachelor 5 14%
Student > Doctoral Student 2 6%
Professor 2 6%
Other 3 8%
Unknown 7 19%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 13 36%
Agricultural and Biological Sciences 6 17%
Medicine and Dentistry 6 17%
Nursing and Health Professions 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 2 6%
Unknown 7 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 85. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 February 2021.
All research outputs
#285,169
of 17,047,319 outputs
Outputs from Blood Cancer Discovery
#4
of 52 outputs
Outputs of similar age
#10,391
of 292,743 outputs
Outputs of similar age from Blood Cancer Discovery
#1
of 19 outputs
Altmetric has tracked 17,047,319 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 52 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 292,743 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.